SHARE

Porton Makes Debut At DCAT Week 2024 To Jointly Promote Industry Development Porton Makes Debut At DCAT Week 2024 To Jointly Promote Industry Development
28.03.2024

Porton Makes Debut At DCAT Week 2024 To Jointly Promote Industry Development

Porton Makes Debut At DCAT Week 2024 To Jointly Promote Industry Development

NEW YORK, NY - From March 18th to March 21st, 2024, Midtown New York City hosted the 96th Annual DCAT Week, renowned as one of the world's largest and most prestigious business events in the pharmaceutical industry. Over four days, hundreds of member companies engaged in high-level customer meetings, typically involving senior management or C-suite executives. This event is a premier gathering held annually in New York City for companies involved in the global Bio/Pharmaceutical manufacturing value chain.


On Monday, Porton Chairman & CEO, Oliver Ju, delivered a presentation at the DCAT Annual Membership Forum, an invite-only platform to highlight exciting company news within the DCAT Member Company network. Mr. Ju presented Porton’s exciting globalization strategy and layout blueprint, showcasing Porton’s new R&D and GMP production site in Slovenia as well as the state-of-the-art DS/DP and HPAPI facility in the United States. Additionally, the presentation also highlighted Porton’s focus on cutting-edge technologies and achievements in one-stop new capabilities like Tides, and how we could optimize process efficiency and cost control during R&D and manufacturing.


At this year's conference, Porton showcased our commitment to customer-centricity by offering innovative and reliable global solutions, reinforcing our leading position as a global CDMO service platform. This strategic focus aligns perfectly with our goal of introducing Porton's advanced technical expertise and client oriented CDMO services to customers in the United States. By participating in this prominent event, the company played a crucial role in establishing Porton as a go-to partner for addressing technical hurdles and launching groundbreaking drugs in the US market.

SHARE

Porton Makes Debut At DCAT Week 2024 To Jointly Promote Industry Development Porton Makes Debut At DCAT Week 2024 To Jointly Promote Industry Development
Porton Experts Invited To Participate In The University Of Perugia Master PRO-API Program, Aiding In The Training Of Green Process Chemistry Professionals Porton Will Be Participating In Biotech Outsourcing Strategies Events This June Proton At CPhI North America Again Porton 2023 ESG Report Upcoming Porton Shows In Europe And The USA:Shaping Our Future Together Porton Makes Debut At DCAT Week 2024 To Jointly Promote Industry Development Join Our Founder And CEO @ DCAT Week Porton Pharma Solutions Joined The SBTi To Drive Climate Action Farewell To 2023, And WE Are Sailing Forward To 2024 The Pharma Crystallization Summit (PCS) Is Held Annually To Bring Together Developers Of New Medicines With Crystallization Challenges And The Crystallization Experts (Solution Providers) In The Industry And Academia. Porton Gets Improved In The 2023 S&P Global ESG Score Porton Pharma Solutions Announces New Flagship Facility Offering Integrated API Crystallization And Drug Product Development Services Pharma Digital Intelligence Summit Will Be Held On 5th, September, 2023 [Important Notice] Porton Announcement Regarding The Change Of Email Domain Porton Unveils Its Small Molecule Platform Headquarters In Shanghai PORTON Starts Construction Of Its Facility For Antibodies And ADCs In Shanghai Porton At DCAT Week 2023: A Highly Successful And Strategic Event Porton Released 2022 CSR Report Porton Delivers Strong 2022 Performance With 127% Sales Growth Porton Gets Above-Average S&P Global Environmental, Social, And Governance (ESG) Score
News

Insights Unveiled: Delve into Our Global News Hub!

22.05.2024

Porton Pharma Solutions embark on the next frontier in Mengeš, Slovenia

  • Opening ceremony of the state-of-the-art research and development laboratories for active pharmaceutical ingredients, small molecules, of Porton in Mengeš

  • A donation of EUR 20,000.00 to the municipality of Mengeš for the restoration of a flooded kindergarten

  • New jobs and further growth in the field of API's small molecules in Slovenia, Mengeš

Read the news

Cookie settings

Your current status

Show details